Published in J Biol Chem on October 28, 1994
Mechanisms of action of glucagon-like peptide 1 in the pancreas. Pharmacol Ther (2006) 2.71
Overexpression of inducible cyclic AMP early repressor inhibits transactivation of genes and cell proliferation in pancreatic beta cells. Mol Cell Biol (2004) 1.28
A novel cyclic adenosine monophosphate responsive luciferase reporter incorporating a nonpalindromic cyclic adenosine monophosphate response element provides optimal performance for use in G protein coupled receptor drug discovery efforts. J Biomol Screen (2007) 1.20
Glucagon-like peptide 1 stimulates insulin gene promoter activity by protein kinase A-independent activation of the rat insulin I gene cAMP response element. Diabetes (2000) 1.16
Exendin-4 as a stimulator of rat insulin I gene promoter activity via bZIP/CRE interactions sensitive to serine/threonine protein kinase inhibitor Ro 31-8220. Endocrinology (2002) 1.00
CRE/CREB-driven up-regulation of gene expression by chronic social stress in CRE-luciferase transgenic mice: reversal by antidepressant treatment. PLoS One (2007) 0.93
CREB mediates the insulinotropic and anti-apoptotic effects of GLP-1 signaling in adult mouse β-cells. Mol Metab (2014) 0.91
Characterization of a novel protein kinase C response element in the glucagon gene. Mol Cell Biol (1997) 0.88
Enhancement by lithium of cAMP-induced CRE/CREB-directed gene transcription conferred by TORC on the CREB basic leucine zipper domain. Biochem J (2007) 0.83
Regulation of human insulin gene transcription by the immunosuppressive drugs cyclosporin A and tacrolimus at concentrations that inhibit calcineurin activity and involving the transcription factor CREB. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.80
TNFα-induced DLK activation contributes to apoptosis in the beta-cell line HIT. Naunyn Schmiedebergs Arch Pharmacol (2017) 0.80
Influence of Bisphenol A on Type 2 Diabetes Mellitus. Int J Environ Res Public Health (2016) 0.75
The role of dual leucine zipper kinase (DLK) in β-cell apoptosis: a potential target for the prevention and treatment of type 2 diabetes? : Commentary to: Börchers et al., TNF-α induced DLK activation contributes to apoptosis in the β-cell line HIT. Naunyn Schmiedebergs Arch Pharmacol (2017) 0.75
Irreversible progression of severe retinopathy in young type I insulin-dependent diabetes mellitus patients after improved metabolic control. J Diabetes Complications (1992) 1.51
Herbaspirillum frisingense sp. nov., a new nitrogen-fixing bacterial species that occurs in C4-fibre plants. Int J Syst Evol Microbiol (2001) 1.39
Rapidly progressive vanishing white matter disease in a child with previously inconspicuous brain MRI. Neuropediatrics (2006) 1.38
Alpha-cell-specific expression of the glucagon gene is conferred to the glucagon promoter element by the interactions of DNA-binding proteins. Mol Cell Biol (1988) 1.35
Female genital schistosomiasis of the lower genital tract: prevalence and disease-associated morbidity in northern Tanzania. J Infect Dis (2000) 1.34
Collateral circulation is an independent radiological predictor of outcome after thrombolysis in acute ischaemic stroke. Neuroradiology (2002) 1.26
Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II study. Mult Scler (2011) 0.99
Cerebral hyperperfusion injury after percutaneous transluminal angioplasty of extracranial arteries. J Neurol (1997) 0.96
Involvement of the Ca(2+)-dependent phosphatase calcineurin in gene transcription that is stimulated by cAMP through cAMP response elements. J Biol Chem (1995) 0.96
Inhibition by antidepressant drugs of cyclic AMP response element-binding protein/cyclic AMP response element-directed gene transcription. Mol Pharmacol (1995) 0.96
Heterodimeric Pbx-Prep1 homeodomain protein binding to the glucagon gene restricting transcription in a cell type-dependent manner. J Biol Chem (2000) 0.94
Inhibition of cAMP-responsive element-mediated gene transcription by cyclosporin A and FK506 after membrane depolarization. J Biol Chem (1993) 0.94
Inhibition of MafA transcriptional activity and human insulin gene transcription by interleukin-1beta and mitogen-activated protein kinase kinase kinase in pancreatic islet beta cells. Diabetologia (2007) 0.94
Gene-specific transcriptional activity of the insulin cAMP-responsive element is conferred by NF-Y in combination with cAMP response element-binding protein. J Biol Chem (1998) 0.93
Inhibition of CREB- and cAMP response element-mediated gene transcription by the immunosuppressive drugs cyclosporin A and FK506 in T cells. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.93
Membrane depolarization and calcium influx induce glucagon gene transcription in pancreatic islet cells through the cyclic AMP-responsive element. J Biol Chem (1993) 0.91
The development and validation of the Unidimensional Fatigue Impact Scale (U-FIS). Mult Scler (2009) 0.90
Stabilization of pre-epithelial mucus gel in cryostat sections from rat colon with celloidin. Stain Technol (1990) 0.89
Molecular study of sheep malignant theileriosis at barka region in the sultanate of oman. Iran J Parasitol (2011) 0.89
Characterization of a novel calcium response element in the glucagon gene. J Biol Chem (1999) 0.88
Characterization of a novel protein kinase C response element in the glucagon gene. Mol Cell Biol (1997) 0.88
Carotidynia: magnetic resonance imaging and ultrasonographic imaging of a self-limiting disease. Clin Neuroradiol (2011) 0.87
Inhibition of membrane depolarisation-induced transcriptional activity of cyclic AMP response element binding protein (CREB) by the dual-leucine-zipper-bearing kinase in a pancreatic islet beta cell line. Diabetologia (2005) 0.86
Role of vasopressin in the ACTH response to isoprenaline. Eur J Pharmacol (1982) 0.86
Tissue-specific transcriptional activity of a pancreatic islet cell-specific enhancer sequence/Pax6-binding site determined in normal adult tissues in vivo using transgenic mice. Mol Endocrinol (1999) 0.86
Plasma elastin-derived peptide levels in normal adults, children, and emphysematous subjects. Physiologic and computed tomographic scan correlates. Am Rev Respir Dis (1992) 0.85
The amount of solid cerebral microemboli during carotid stenting does not relate to the frequency of silent ischemic lesions. AJNR Am J Neuroradiol (2006) 0.85
Isolated symptomatic stenosis of the middle cerebral artery in younger adults. A clinical and ultrasonic follow-up study of eight patients. Eur Neurol (1996) 0.85
The immunosuppressive drugs cyclosporin A and FK506 inhibit calcineurin phosphatase activity and gene transcription mediated through the cAMP-responsive element in a nonimmune cell line. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.85
Cerebral magnetic resonance imaging findings in adults with haemolytic uraemic syndrome following an infection with Escherichia coli, subtype O104:H4. Clin Neuroradiol (2013) 0.85
Effect of isoprenaline and trimethidinium on the plasma vasopressin concentration in conscious rats. Arch Int Pharmacodyn Ther (1980) 0.85
Analysis of 20 primarily surgically treated chiasmatic/hypothalamic pilocytic astrocytomas. Acta Neurochir (Wien) (1994) 0.84
Effects of a kappa-opioid agonist on adrenocorticotropic and diuretic function in man. Horm Metab Res (1986) 0.84
Evidence for the involvement of a GABA-mediated inhibition in the hypovolaemia-induced vasopressin release. Pflugers Arch (1980) 0.83
Adrenocorticotropin and beta-endorphin release from rat adenohypophysis in vitro: inhibition by prostaglandin E2 formed locally in response to vasopressin and corticotropin-releasing factor. Endocrinology (1984) 0.83
On the mechanism of the vasopressin-induced inhibition of renin release. Horm Metab Res (1982) 0.83
Insulin responsiveness of the glucagon gene conferred by interactions between proximal promoter and more distal enhancer-like elements involving the paired-domain transcription factor Pax6. J Biol Chem (2000) 0.83
Calcium-mobilizing insulin secretagogues stimulate transcription that is directed by the cyclic adenosine 3',5'-monophosphate/calcium response element in a pancreatic islet beta-cell line. Endocrinology (1996) 0.83
Restitution of neurophysiological functions, performance, and subjective symptoms after moderate insulin-induced hypoglycaemia in non-diabetic men. Diabet Med (1996) 0.82
Loss of insulin-induced inhibition of glucagon gene transcription in hamster pancreatic islet alpha cells by long-term insulin exposure. Diabetologia (2008) 0.82
Small bowel obstruction following anticoagulant therapy. Report of a case and review of the literature. Am J Gastroenterol (1965) 0.81
Naloxone promotes stimulus-evoked vasopressin release in vivo. Eur J Pharmacol (1980) 0.81
Inhibition of cyclic AMP response element-binding protein/cyclic AMP response element-mediated transcription by the immunosuppressive drugs cyclosporin A and FK506 depends on the promoter context. Mol Pharmacol (1999) 0.81
GRF elevates cytosolic free calcium concentration in rat anterior pituitary cells. Am J Physiol (1987) 0.81
In vitro CRF activity of vasopressin analogs is not related to pressor activity. Eur J Pharmacol (1983) 0.81
Vasopressin and beta-endorphin release after osmotic and non-osmotic stimuli: effect of naloxone and dexamethasone. Eur J Pharmacol (1982) 0.81
Top concentrations of dynorphin-like immunoreactivity in fractions of rat anterior pituitary cells enriched in gonadotrophs. Life Sci (1986) 0.81
Evidence for inhibition by beta-endorphin of vasopressin release during foot shock-induced stress in the rat. Neuroendocrinology (1982) 0.81
Cloning, and Molecular Characterization of Polymorphic Iranian Isolate Theileria annulata Surface Protein (Tasp). Iran J Parasitol (2012) 0.81
Effect of transection of subfornical organ efferent projections on vasopressin release induced by angiotensin or isoprenaline in the rat. Brain Res (1982) 0.80
Cholecystokinin-like immunoreactivity of rat medial basal hypothalamus: investigations on a possible hypophysiotropic function. Neuroendocrinology (1983) 0.80
The effect of naloxone on vasopressin release from rat neurohypophysis incubated in vitro. J Physiol (1983) 0.80
[Spinal dural arteriovenous fistula: clinical and radiological findings in 54 patients]. Rofo (2003) 0.79
A formal model of diabetological terminology and its application for data entry. Stud Health Technol Inform (1997) 0.79
Effect of human growth hormone-releasing hormone on the release of dynorphin-like immunoreactivity, luteinizing hormone, and follicle-stimulating hormone from rat adenohypophysis in vitro. Endocrinology (1987) 0.79
Delayed onset of post-rabies vaccination encephalitis. Ann Neurol (1983) 0.79
Potassium depolarization elevates cytosolic free calcium concentration in rat anterior pituitary cells through 1,4-dihydropyridine-sensitive, omega-conotoxin-insensitive calcium channels. Endocrinology (1988) 0.79
Release of dynorphin-like immunoreactivity of rat neurohypophysis in comparison to vasopressin after various stimuli in vitro and in vivo. Neurosci Lett (1982) 0.79
In vitro adrenocorticotropin/beta-endorphin-releasing activity of vasopressin analogs is related neither to pressor nor to antidiuretic activity. Endocrinology (1984) 0.79
The diagnostic relevance of colour Doppler artefacts in carotid artery examinations. Eur J Radiol (2004) 0.78
Presence of Schistosoma mansoni eggs in the cervix uteri of women in Mwanga District, Tanzania. Trans R Soc Trop Med Hyg (2001) 0.78
Stimulation of adrenocorticotropin/beta-endorphin release by synthetic ovine corticotropin-releasing factor in vitro. Enhancement by various vasopressin analogs. Neuroendocrinology (1984) 0.78
Effect of prostaglandin E2 on ACTH and beta-endorphin release from rat adenohypophysis in vitro after secretagogues which can mimic various first or second messengers. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.78
Brain and platelet monoamine oxidase in mental disorders 1. Schizophrenics and cycloid psychotics. Prog Neuropsychopharmacol (1980) 0.78
Stimulation by melittin of adrenocorticotropin and beta-endorphin release from rat adenohypophysis in vitro. Prostaglandins (1987) 0.78
Vasopressin stimulates release of beta-lipotropin and beta-endorphin in conscious rats as measured by radioimmunoassay of unextracted plasma. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.78
Effect of various blockers of arachidonic acid metabolism on release of beta-endorphin- and adrenocorticotropin-like immunoreactivity induced by phospholipase A2 from rat adenohypophysis in vitro. Neuroendocrinology (1986) 0.77
Vasopressin release from rat medial basal hypothalamus induced in vitro by angiotensin. Eur J Pharmacol (1982) 0.77
Effect of captopril (SQ 14 225) on vasopressin release induced by angiotensin in the conscious rat. Clin Sci (Lond) (1982) 0.77
Role of the renin-angiotensin system in isoprenaline-induced vasopressin release. J Cardiovasc Pharmacol (1981) 0.77
Foot shock stress-induced release of vasopressin in adenohypophysectomized and hypophysectomized rats. Endocrinology (1985) 0.77
Nuclear protein binding and functional activity of a variant insulin gene found in non-insulin-dependent diabetes mellitus. Exp Clin Endocrinol Diabetes (1996) 0.77
The effect of isoprenaline on plasma concentrations of immunoreactive beta-endorphin and beta-lipotropin in the conscious rat. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.77
Histamine PC(20) extrapolation. Chest (2000) 0.77
Multiple vascular abnormalities and a paradoxical combination of vitamin B12 deficiency and thrombocytosis in a case with POEMS syndrome. J Neurol (2003) 0.77
Beta-endorphin and adrenocorticotropin release from rat adenohypophysis in vitro: evidence for local modulation by arachidonic acid metabolites of the cyclooxygenase and lipoxygenase pathway. Neuroendocrinology (1984) 0.76
Evidence that vasopressin is involved in the isoprenaline-induced beta-endorphin release. Eur J Pharmacol (1980) 0.76
Interaction of the transcription factor CREB with pancreatic islet cell-specific enhancer elements. Biol Chem Hoppe Seyler (1995) 0.76
Inhibition by morphine and beta-endorphin of vasopressin release evoked by electrical stimulation of the rat medial basal hypothalamus in vitro. Brain Res (1982) 0.76
Angiographic follow-up of vertebrobasilar artery aneurysms treated with detachable coils. Neuroradiology (2003) 0.75
Development of a Reverse Line Blot Hybridization method for Detection of some Streptococcal/Lactococcal Species, the causative agents of Zoonotic Streptococosis/Lactococosis in farmed fish. Iran J Microbiol (2012) 0.75
Corelease of dynorphin-like immunoreactivity, luteinizing hormone, and follicle-stimulating hormone from rat adenohypophysis in vitro. Endocrinology (1985) 0.75
Release of beta-lipotropin- and beta-endorphin-like material induced by angiotensin in the conscious rat. Br J Pharmacol (1982) 0.75
Influence of converting enzyme inhibition on the release of vasopressin induced by angiotensin. Br J Pharmacol (1980) 0.75
cAMP- and diacylglycerol-mediated pathways elevate cytosolic free calcium concentration via dihydropyridine-sensitive, omega-conotoxin-insensitive calcium channels in normal rat anterior pituitary cells. Naunyn Schmiedebergs Arch Pharmacol (1989) 0.75
["High-flow" pulmonary arteriovenous malformations--endovascular therapy with a vena cava filter]. Rofo (2008) 0.75
Loss of alleles in brain tumours: distribution and correlations with clinical course. J Neurol (1995) 0.75
Clinical and ultrasonic long-term results of percutaneous transluminal carotid angioplasty. A prospective follow-up of 30 carotid angioplasties. Cerebrovasc Dis (1998) 0.75
Competition between drives for intracranial stimulation and sodium chloride by adrenalectomized NaCl-deprived rats. J Comp Physiol Psychol (1967) 0.75
[Primary amyloidosis AL as a cause of restrictive cardiomyopathy]. Z Kardiol (1997) 0.75
Glucagon gene G3 enhancer: evidence that activity depends on combination of an islet-specific factor and a winged helix protein. Biol Chem (1997) 0.75
Cerebrocutaneous xanthoma disseminatum and disseminated demyelinating encephalomyelitis. Eur Neurol (2000) 0.75
[Coiling vs. clipping: hospital stay and procedure time in intracranial aneurysm treatment]. Rofo (2009) 0.75
[In Process Citation]. Clin Neuroradiol (2015) 0.75
Individualized low-dose growth hormone (GH) treatment in GH-deficient adults with childhood-onset disease: metabolic effects during fasting and hypoglycemia. Metabolism (1999) 0.75